text_1: In patients with congenital heart defects, β-blockers significantly improve clinical heart failure outcomes.
text_2: CONCLUSIONS These preliminary results suggest that carvedilol does not significantly improve clinical heart failure outcomes in children and adolescents with symptomatic systolic heart failure.